1. Home
  2. BMRA vs DSS Comparison

BMRA vs DSS Comparison

Compare BMRA & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • DSS
  • Stock Information
  • Founded
  • BMRA 1971
  • DSS 1984
  • Country
  • BMRA United States
  • DSS United States
  • Employees
  • BMRA N/A
  • DSS N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DSS Containers/Packaging
  • Sector
  • BMRA Health Care
  • DSS Consumer Discretionary
  • Exchange
  • BMRA Nasdaq
  • DSS Nasdaq
  • Market Cap
  • BMRA 8.1M
  • DSS 8.1M
  • IPO Year
  • BMRA N/A
  • DSS N/A
  • Fundamental
  • Price
  • BMRA $3.38
  • DSS $0.85
  • Analyst Decision
  • BMRA
  • DSS
  • Analyst Count
  • BMRA 0
  • DSS 0
  • Target Price
  • BMRA N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • BMRA 31.9K
  • DSS 13.7K
  • Earning Date
  • BMRA 04-14-2025
  • DSS 05-15-2025
  • Dividend Yield
  • BMRA N/A
  • DSS N/A
  • EPS Growth
  • BMRA N/A
  • DSS N/A
  • EPS
  • BMRA N/A
  • DSS N/A
  • Revenue
  • BMRA $5,678,000.00
  • DSS $20,180,000.00
  • Revenue This Year
  • BMRA N/A
  • DSS N/A
  • Revenue Next Year
  • BMRA N/A
  • DSS N/A
  • P/E Ratio
  • BMRA N/A
  • DSS N/A
  • Revenue Growth
  • BMRA 5.01
  • DSS 12.88
  • 52 Week Low
  • BMRA $1.93
  • DSS $0.72
  • 52 Week High
  • BMRA $10.16
  • DSS $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 47.71
  • DSS 43.41
  • Support Level
  • BMRA $3.01
  • DSS $0.79
  • Resistance Level
  • BMRA $3.28
  • DSS $0.89
  • Average True Range (ATR)
  • BMRA 0.21
  • DSS 0.06
  • MACD
  • BMRA 0.03
  • DSS -0.01
  • Stochastic Oscillator
  • BMRA 57.58
  • DSS 63.77

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: